SLAMF1/CD150, SLAMF2/CD48, and SLAMF7/CD319 were found to be downregulated while SLAMF3/CD229, SLAMF5/CD84, and SLAMF6/CD352 were overexpressed in CLL. Here, CD84 is linked to B-cell chronic lymphocytic leukemia.